Functional relevance of IL-10 promoter polymorphisms for sepsis development

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Stanilova, Spaska A ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE;

ALLELE; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; HOST RESISTANCE; HUMAN; INJURY; MULTIPLE ORGAN FAILURE; NOTE; PRIORITY JOURNAL; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; GENETIC POLYMORPHISM; GENETICS;

ALLELES; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; POLYMORPHISM, GENETIC; SEPSIS;

EID: 77956642605     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8839     Document Type: Note

References (9)

1. Ling Z, Wei G, Kehong C, Dongpo J, Lianyang Z, Dingyuan D, Ping H, Qing L, Suna H, Jianxin J. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care 2009, 13:R188. 2811917, 19939284, 10.1186/cc8182.
2. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
3. Stuber F. Effect of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?. J Am Soc Nephrol 2001, 12:S60-S64.
4. Stanilova S, Miteva L, Karakolev Z, Stefanov C. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006, 32:260-266. 10.1007/s00134-005-0022-4, 16435103.
5. Gogos C, Drosou E, Bassaris H, Skoutelis A. Pro versus anti-inflammatory cytokine profile in patiens with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180. 10.1086/315214, 10608764.
6. Latifi SQ, O'Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002, 70:4441-4446. 128185, 12117955, 10.1128/IAI.70.8.4441-4446.2002.
7. Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS. High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 2005, 31:401-407. 10.1007/s00134-005-2575-7, 15719148.
8. Bozza F, Salluh J, Japiassu A, Soares M, Assis E, Gomes R, Bozza M, Castro-Faria-Neto H, Bozza P. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49. 2206478, 17448250, 10.1186/cc5783.
9. Shu Q, Fang X, Chen Q, Stuber F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl) 2003, 116:1756-1759.